Human clinical trials of potential Covid-19 vaccine ‘COVAXIN’ begins at AIIMS

The human clinical trials of potential Covid-19 vaccine called COVAXIN has started at AIIMS, New Delhi. The first dose was given to a 30-year-old man in AIIMS-Delhi on Friday.

Indian Council of Medical Research and Bharat Biotech have joined hands for the development of Covaxin. AIIMS-Delhi is among the 12 sites selected by the Indian Council for Medical Research for conducting phase I and II human trials of COVAXIN. In phase I, the vaccine would be tested on 375 volunteers and the maximum of 100 of them would be from AIIMS.

Healthy volunteers having no comorbid conditions and without a history of COVID-19, aged more than 18 years and less than 55 years, would be eligible to participate in the randomised, double-blind, placebo-controlled clinical trial.